COCETTA, VERONICA
 Distribuzione geografica
Continente #
NA - Nord America 2.136
EU - Europa 879
AS - Asia 378
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 1
SA - Sud America 1
Totale 3.398
Nazione #
US - Stati Uniti d'America 2.135
IT - Italia 618
CN - Cina 203
SG - Singapore 148
SE - Svezia 76
UA - Ucraina 36
FR - Francia 35
FI - Finlandia 34
GB - Regno Unito 24
DE - Germania 17
IN - India 17
NL - Olanda 15
CH - Svizzera 10
IE - Irlanda 7
ES - Italia 3
LK - Sri Lanka 3
SA - Arabia Saudita 3
PT - Portogallo 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BR - Brasile 1
CA - Canada 1
DZ - Algeria 1
EU - Europa 1
HK - Hong Kong 1
MA - Marocco 1
SI - Slovenia 1
ZA - Sudafrica 1
Totale 3.398
Città #
Fairfield 291
Chandler 222
Padova 194
Ashburn 181
Woodbridge 147
Cambridge 145
Ann Arbor 133
Seattle 119
Houston 107
Wilmington 104
Singapore 99
Medford 68
Princeton 68
Beijing 53
Des Moines 44
Milan 37
San Diego 36
Boardman 29
Helsinki 29
Malo 26
Nanjing 26
Roxbury 21
Santa Clara 19
Rome 18
Palermo 14
Washington 12
Parma 11
Arezzo 10
Cagliari 10
Catania 10
Shenyang 9
Amsterdam 8
Dallas 8
Jinan 8
Redwood City 8
Vicenza 8
Bologna 7
Dublin 7
Naples 7
Changsha 6
Guangzhou 6
Hebei 6
Lugano 6
Nanchang 6
Duncan 5
London 5
New York 5
Ningbo 5
Torino 5
Treviso 5
Verona 5
Borås 4
Hefei 4
Pisa 4
Pune 4
Zhengzhou 4
Agordo 3
Assemini 3
Bagnolo del Salento 3
Borgomanero 3
Erandio 3
Florence 3
Gorlago 3
Hangzhou 3
Kilburn 3
Kunming 3
Lappeenranta 3
Napoli 3
Norwalk 3
Phoenix 3
Tianjin 3
Acton 2
Avellino 2
Bassano Del Grappa 2
Breganze 2
Cabras 2
Calcinate 2
Caronno Varesino 2
Catanzaro 2
Chengdu 2
Clermont-Ferrand 2
Clifton 2
Cologna Veneta 2
Corridonia 2
Este 2
Haikou 2
Hardinxveld-Giessendam 2
Isola di Capo Rizzuto 2
Jeddah 2
Jesolo 2
Jiaxing 2
Lanzhou 2
Livorno 2
Los Angeles 2
Marano di Napoli 2
Martellago 2
Messina 2
Modigliana 2
Mogliano Veneto 2
Monopoli 2
Totale 2.541
Nome #
Anti-senescence activity of Salvia haenkei on skin cellular model identified by integrated senescence-screening assay 185
Mitochondrial Involvement in Cisplatin Resistance 169
Cisplatin liposome and 6-amino nicotinamide combination to overcome drug resistance in ovarian cancer cells 134
Peculiar combinations of individually non-pathogenic missense mitochondrial DNA variants cause low penetrance Leber’s hereditary optic neuropathy 126
Identification of Salvia haenkei as gerosuppressant agent by using an integrated senescence-screening assay 121
A fixed combination of probiotics and herbal extracts attenuates intestinal barrier dysfunction from inflammatory stress in an in vitro model using Caco-2 cells. 118
Effects of Boswellia Serrata Roxb. and Curcuma longa L. in an In Vitro Intestinal Inflammation Model Using Immune Cells and Caco-2 101
Silybin counteracts doxorubicin resistance by inhibiting GLUT1 expression 96
Protective effects of ψ taraxasterol 3-O-myristate and arnidiol 3-O-myristate isolated from Calendula officinalis on epithelial intestinal barrier 93
New insights in cisplatin-resistance: role of metabolic reprogramming in cancer cells 81
Anti-ageing activity of Salvia haenkei in an in vitro epidermal model 70
Potential effect of Salvia Haenkey on in vitro wound healing 69
Further assessment of Salvia haenkei as an innovative strategy to counteract skin photo-aging and restore the barrier integrity 69
Serenoa repens and Urtica dioica Fixed Combination: In-Vitro Validation of a Therapy for Benign Prostatic Hyperplasia (BPH) 64
Interaction between Mitochondrial DNA Variants and Mitochondria/Endoplasmic Reticulum Contact Sites: A Perspective Review 63
Overcome cisplatin -resistance by targetin glucose-6-phosphate dehydrogenase with the combination of liposomal cisplatin and 6-amino nicotinamide 59
Plumbagin Induces Cell Cycle Arrest and Apoptosis in A431 Cisplatin-Resistant Cancer Cells 55
Cholesterol Metabolic Reprogramming in Cancer and Its Pharmacological Modulation as Therapeutic Strategy 54
SILYBIN: A NATURAL COMPOUND ABLE TO OVERCOME DOXORUBICIN RESISTANCE PHENOMENA 50
Anti-senescence activity of Salvia Haenkei on a skin cellular model 48
Inhibition of Glucose-6-Phosphate Dehydrogenase Reverses CisplatinResistance: new pharmacological approach using Cisplatin liposome and 6-amino nicotinamide combination 48
In Vitro Cultured Melissa officinalis Cells as Effective Ingredient to Protect Skin Against Oxidative Stress, Blue Light, and Infrared Irradiations Damages 48
Metabolic reprogramming in triple negative breast cancer cells: role of glutamine and glucose in cisplatin resistance 45
Study of metabolic reprogramming and identification of new pharmacological targets in chemotherapy resistance 44
Silybin chemosensitize doxorubicin-resistant cells by targeting GLUT1 43
Lipid-metabolic reprogramming in ovarian carcinoma cell lines resistant to cisplatin 43
IDENTIFICAZIONE DI ESTRATTI NATURALI CON PROMETTENTE APPLICAZIONE IN FITOCOSMESI 43
Cannabidiol Isolated From Cannabis sativa L. Protects Intestinal Barrier From In Vitro Inflammation and Oxidative Stress 43
Clinical evidence of interaction between nutraceutical supplementation and platinum-based chemotherapy 43
Cannabis Sativa modulates epithelial permeability in an in vitro intestinal inflammation model 41
Links between cancer metabolism and cisplatin resistance 41
Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants 41
Resveratrol as Chemosensitizer Agent: State of Art and Future Perspectives 40
Role of mitochondria in cisplatin-resistance phenomena 37
Mitochondrial remodeling involved in cisplatin resistance 36
Cisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy 36
Silybin as a new tool to counteract doxorubicin resistance by targeting glucose uptake 35
Cannabis Sativa L. modulates epithelial permeability in an in vitro intestinal inflammation model 35
Mitochondrial alterations involved in cisplatin resistance phenomena 34
Mitochondria as cisplatin targets: new apporach to counteract resistance mechanism 33
Curcumin and Cisplatin as new chemotherapeutic compounds in order to overcome cisplatin resistance 33
Cybrid cell model to study the effect of estrogen-like compounds on LHON dysfunctional mitochondria 33
Natural polyphenol sensitize cancer cells to cisplatin effect on cell cycle 32
Cybrid cell model to study the effect of estrogen-like compounds on LHON dysfunctional mitochondria 32
UN NAFTOCHINONE ESTRATTO DALLA PIANTA PLUMBAGO ZEYLANICA L. INDUCE MORTE CELLULARE DELLE CELLULE RESISTENTI AL CISPLATINO 31
Natural compounds as metabolic modulators in resistant cancer cells models 30
VALIDAZIONE IN VITRO DI UNA COMBINAZIONE DI SERENOA REPENS E URTICA DIOICA PER LA TERAPIA DELL'IPERPLASIA PROSTATICA BENIGNA 30
GLUTAMINE METABOLISM IN TRIPLE-NEGATIVE BREAST CANCER AND ITS ROLE IN CISPLATIN RESISTANCE 29
Study of quercetin chemosensitization effect in cisplatin-resistant cancer cell models 29
Contribution of Mitochondrial Activity to Doxorubicin-Resistance in Osteosarcoma Cells 28
Natural polyphenols as chemosensitizer: studies in resistant cancer cells. 28
Novel Adenosine Triphosphate-Based Nutraceutical Formulation to Prevent Non-Steroidal Anti-Inflammatory Drug Enteric Cell Toxicity: Preliminary In Vitro Evidence 28
Imbalance of mitochondrial "shaping proteins" and cisplatin resistance 27
Mitophagic/autophagic inhibitors as new strategy to overcome cisplatin resistance in cancer 27
The SARS-CoV-2 spike protein binds and modulates estrogen receptors 27
CHARACTERIZATION OF MITOCHONDRIAL METABOLISM OF DOXORUBICIN-RESISTANT OSTEOSARCOMA CELLS 26
Natural compounds as metabolic modulators in resistant cancer models 26
Natural compounds as possible modulators of lipid metabolism in cisplatin-resistant cancer cells 26
Study of quercetin chemosensitization effect in cisplatin-resistant cancer cell models 26
Sviluppo di un decongestionante nasale a base fitoterapica 26
Targeting glucose-6-phosphate dehydrogenase by 6-amino nicotinamide in combination with liposomal cisplatin as a strategy to sensitize ovarian resistant cancer cells 26
Natural compounds as metabolic modulators in resistant cancer cell models 25
Calu-3 cells as in vitro model of bronchial epithelium for pharmacological studies of natural compounds 23
Silybin glycolysis inhibitor as promising agent in chemotherapy 23
Mitochondrial phenotyping of doxorubicin-resistant osteosarcoma cells 23
Antioxidant and anti-inflammatory activities of Cannabis Sativa in epithelial intestinal cell 22
Natural polyphenols chemosensitize cisplatin-resistant cells through cell cycle modulation 22
Clinical outcome of SARS-CoV-2 infection in breast and ovarian cancer patients who underwent antiestrogenic therapy 21
VALUTAZIONE DELL’ATTIVITA’ ANTI-INVECCHIAMENTO DELL’ESTRATTO AS PER APPLICAZIONE FITOCOSMETICA 20
Silybin, curcumin and quercetin as metabolic modulators in human resistant cancer cells 20
Targeting glucose-6-phosphate dehydrogenase with a combination of liposomal cisplatin and 6-amino nicotinamide as new strategy to overcome cisplatin-resistance 19
Anti-inflammatory activity of a fixed combination of probiotics and herbal extract in an in-vitro model of intestinal inflammation by stimulating Caco-2 cells with LPS-conditioned THP-1 cells medium 18
Milk kefir enriched with inulin-grafted seed extract from white wine pomace: chemical characterisation, antioxidant profile and in vitro gastrointestinal digestion 17
Totale 3.487
Categoria #
all - tutte 15.026
article - articoli 9.116
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 149
Totale 24.291


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020446 0 0 0 51 37 19 100 53 74 67 28 17
2020/2021533 20 26 31 43 27 30 65 40 65 68 84 34
2021/2022667 17 117 42 22 23 69 27 39 80 16 29 186
2022/2023595 129 46 21 36 120 59 6 32 80 3 47 16
2023/2024530 24 59 56 43 40 75 48 70 11 10 36 58
2024/2025343 110 94 83 56 0 0 0 0 0 0 0 0
Totale 3.487